Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

BTMD

biote Corp

May 02 • 02:32PM ET

5.68

Dollar change +0.03
Percentage change 0.53	%

Healthcare • Medical Care Facilities • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWM IWN VTWO IWO OMFS IWC EES SQLV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.27	Insider Own	6.72%	Shs Outstand	34.25M	Perf Week	1.79%
Market Cap	202.83M	Forward P/E	9.59	EPS next Y	0.59	Insider Trans	0.00%	Shs Float	33.31M	Perf Month	-3.73%
Income	3.32M	PEG	-	EPS next Q	0.05	Inst Own	48.46%	Short Float	3.09%	Perf Quarter	42.00%
Sales	185.36M	P/S	1.09	EPS this Y	198.08%	Inst Trans	6.65%	Short Ratio	8.89	Perf Half Y	6.57%
Book/sh	-0.86	P/B	-	EPS next Y	52.90%	ROA	2.48%	Short Interest	1.03M	Perf Year	-8.53%
Cash/sh	2.49	P/C	2.28	EPS next 5Y	-	ROE	-	52W Range	3.65 - 8.22	Perf YTD	14.98%
Dividend Est.	-	P/FCF	7.65	EPS past 5Y	-19.96%	ROI	4.20%	52W High	-30.90%	Beta	0.87
Dividend TTM	-	Quick Ratio	4.56	Sales past 5Y	14.07%	Gross Margin	67.16%	52W Low	55.45%	ATR (14)	0.28
Dividend Ex-Date	-	Current Ratio	5.51	EPS Y/Y TTM	-220.48%	Oper. Margin	17.92%	RSI (14)	50.00	Volatility	4.62% 4.25%
Employees	194	Debt/Eq	-	Sales Y/Y TTM	12.37%	Profit Margin	1.79%	Recom	1.00	Target Price	8.65
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	342.39%	Payout	0.00%	Rel Volume	0.41	Prev Close	5.65
Sales Surprise	-0.24%	EPS Surprise	118.18%	Sales Q/Q	2.74%	Earnings	May 07 AMC	Avg Volume	115.70K	Price	5.68
SMA20	-0.47%	SMA50	-2.64%	SMA200	6.60%	Trades		Volume	37,374	Change	0.53%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-20-24	Initiated	B. Riley Securities	Buy	$9
Feb-01-24	Initiated	Jefferies	Buy
Jun-24-22	Initiated	Cowen	Outperform	$11
Jun-23-22	Initiated	ROTH Capital	Buy	$9

Apr-30-24 10:00AM	Earnings Preview: biote Corp. (BTMD) Q1 Earnings Expected to Decline (Zacks)
Apr-29-24 04:05PM	Biote Announces Definitive Settlement with Founder (Business Wire)
Apr-23-24 04:05PM	Biote Schedules First Quarter 2024 Financial Results Release and Conference Call (Business Wire)
Mar-13-24 08:37AM	biote Corp. (PNK:BTMD) Q4 2023 Earnings Call Transcript (Insider Monkey) +14.91%
Mar-12-24 06:11PM	Biote Corp (BTMD) Reports Growth Amidst Challenges in Q4 and Full Year 2023 (GuruFocus.com)
04:05PM	Loading…
04:05PM	Biote Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Mar-05-24 10:00AM	Analysts Estimate biote Corp. (BTMD) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-27-24 04:05PM	Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call (Business Wire) +11.81%
Feb-20-24 04:05PM	Biote Announces Agreement to Resolve Litigation and Repurchase All of Founders Shares (Business Wire)
Jan-25-24 04:05PM	Biote Announces $20 Million Share Repurchase Authorization (Business Wire)
Jan-17-24 04:05PM	Biote to Purchase Asteria Health (Business Wire)
04:05PM	Biote Provides Preliminary 2023 Results and Initial 2024 Guidance (Business Wire)
Jan-11-24 04:05PM	Biote Names Robert Peterson as Chief Financial Officer (Business Wire)
Nov-07-23 08:25PM	Biote Corp. (BTMD) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:45PM	Biote Reports Third Quarter 2023 Financial Results (Business Wire)
08:30AM	Loading…
Oct-24-23 08:30AM	Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call (Business Wire)
Aug-10-23 06:40PM	Biote Corp. (BTMD) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:30PM	Biote Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-27-23 08:30AM	Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call (Business Wire)
Jul-13-23 09:29AM	12 Best Multibagger Penny Stocks To Buy (Insider Monkey)
Jun-22-23 07:00AM	Biote Formalizes Commitment to Mens Hormone Health With Launch of New Mens Health Division (Business Wire)
Jun-08-23 06:05PM	Biote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants (Business Wire)
Jun-05-23 07:48AM	Biote Announces Pricing of Secondary Offering of Common Stock (Business Wire)
May-31-23 08:30AM	Biote to Participate at Upcoming Investor Conferences (Business Wire)
May-30-23 08:30AM	Biote Appoints Mary J. Puncochar as Chief Commercial Officer (Business Wire)
May-09-23 05:21PM	Biote Reports First Quarter 2023 Financial Results (Business Wire) -7.25%
05:21PM	Biote Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants (Business Wire)
Apr-26-23 08:30AM	Biote Schedules First Quarter 2023 Financial Results Release and Conference Call (Business Wire)
Apr-10-23 08:30AM	Biote Names John Denne as General Manager, Mens Health Division (Business Wire)
Mar-31-23 09:55AM	Does biote Corp. (BTMD) Have the Potential to Rally 82.51% as Wall Street Analysts Expect? (Zacks) +9.36%
04:15PM	Loading…
Mar-28-23 04:15PM	Biote Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
Mar-27-23 09:00AM	Study: Testosterone Pellet Therapy Significantly Improves Bone Density in Male Patient Case Report (Business Wire)
Mar-02-23 08:00AM	Biote to Present at 35th Annual Roth Conference (Business Wire)
Feb-09-23 04:15PM	Biote Schedules Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call (Business Wire)
Jan-09-23 05:30PM	Biote Announces Closing of Secondary Offering of 8,500,000 Shares of Common Stock Including Full Exercise of the Underwriters Over-Allotment Option (Business Wire)
Jan-05-23 06:00AM	Biote Announces Pricing of Secondary Offering of Common Stock (Business Wire)
Nov-10-22 08:30AM	Biote to Present at Jefferies London Healthcare Conference (Business Wire)
Nov-08-22 04:15PM	Biote Reports Third Quarter Financial Results (Business Wire)
Nov-07-22 09:15AM	Biote Appoints Debby Morris to Board of Directors (Business Wire) -7.29%
Oct-31-22 08:30AM	Biote Schedules Third Quarter 2022 Financial Results Release and Conference Call (Business Wire)
Oct-10-22 07:45AM	Biote Releases Updated Corporate Presentation for October 2022 (Business Wire)
Sep-07-22 08:30AM	Biote Announces Their Strategic Partnership with IMAC Holdings, Inc. (Business Wire)
08:30AM	Biote Announces Strategic Partnership with IMAC Holdings, Inc. (GlobeNewswire)
Aug-25-22 04:05PM	Biote Announces Approval to Relist on The Nasdaq Stock Market (Business Wire)
Aug-24-22 08:30AM	Biote Appoints Samar Kamdar as Chief Financial Officer (Business Wire) +14.64%
Aug-15-22 04:56PM	Biote Issues Correction to Second Quarter Operating Loss and Net Income (Business Wire)
Aug-09-22 04:15PM	Biote Reports Second Quarter 2022 Financial Results (Business Wire)
Jul-20-22 11:00AM	Biote to Report Second Quarter 2022 Financial Results on August 9, 2022 and Host Conference Call on August 10, 2022 (Business Wire) -8.14%
Jul-18-22 10:24AM	How Much Of biote Corp. (NASDAQ:BTMD) Do Insiders Own? (Simply Wall St.) +7.56%
Jun-16-22 08:30AM	Biote Appoints Ross W. McQuivey, M.D. as Chief Medical Officer (Business Wire)
Jun-06-22 04:05PM	Biote Announces Participation in the Jefferies Healthcare Conference 2022 (Business Wire) -23.55%
08:16AM	National Women in the Workplace Survey: Women with Menopausal Symptoms Suffer in Silence in the Workplace (Business Wire)
Jun-03-22 08:59AM	Earnings growth of 806% over 1 year hasn't been enough to translate into positive returns for biote (NASDAQ:BTMD) shareholders (Simply Wall St.) +8.89%
May-26-22 04:05PM	Biote Debuts as Publicly Traded Company Focused on Transforming Hormone Optimization Industry (Business Wire) -9.07%

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company is headquartered in Irving, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Conlon Mary Elizabeth	General Counsel	Jul 05 '23	Sale	6.50	6,240	40,573	140,393	Jul 06 12:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BTMD

biote Corp

Upgrade your FINVIZ experience